CDH1 and prostate cancer: In contrast, circAMOTL1L is downregulated in human prostate cancer, and reduced circAMOTL1L facilitates the migration and invasion of prostate cancer cells by downregulating E-cad and upregulating vimentin, thereby leading to EMT and prostate cancer progression [13].